| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.54% | 80.31% | 83.60% | 83.82% | 85.01% | 85.03% | 87.06% | 84.97% | 83.06% |
| Operating Margin | 23.05% | 28.50% | 39.76% | 43.55% | 46.84% | 35.34% | 38.13% | 23.45% | 16.74% |
| EBITDA Margin | 23.23% | 28.69% | 39.89% | 43.70% | 46.98% | 35.54% | 38.32% | 23.63% | 17.12% |
| Net Margin | 25.33% | 45.91% | 40.22% | 35.56% | 46.14% | 36.40% | 39.11% | 22.33% | 16.50% |
| Current Ratio | 9.88 | 10.23 | 13.18 | 7.67 | 9.07 | 8.27 | 6.56 | 2.64 | — |
| Quick Ratio | 8.83 | 9.38 | 12.48 | 7.19 | 8.66 | 7.84 | 6.27 | 2.41 | — |
| Debt / Equity | — | — | — | — | — | — | — | — | — |
| ROE | 13.73% | 25.76% | 25.14% | 29.66% | 39.68% | 29.37% | 34.01% | 50.07% | — |
| ROA | 12.24% | 23.07% | 22.93% | 25.06% | 34.47% | 25.37% | 28.00% | 27.60% | — |
| Asset Turnover | 0.48 | 0.50 | 0.57 | 0.70 | 0.75 | 0.70 | 0.72 | 1.24 | — |
| Book Value / Share | 10.44 | 8.73 | 9.16 | 6.38 | 4.83 | 6.07 | 4.72 | 1.28 | — |
InMode Ltd. designs, develops, manufactures, and markets innovative medical aesthetic devices powered by proprietary radiofrequency technology. The company specializes in minimally invasive platforms for procedures like liposuction with skin tightening, body and face contouring, ablative skin rejuvenation, and treatments for women's health conditions. Its non-invasive products address permanent hair reduction, facial rejuvenation, wrinkle reduction, cellulite treatment, skin texture improvement, and superficial vascular or pigmented lesions. Additionally, hands-free devices target skin tightening, fat reduction, and muscle stimulation. InMode Ltd. serves specialties including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. Products reach physicians and clinics in the United States, Canada, Europe, Japan, Australia, India, and other international markets through a network of distributors. Founded in 2008 and headquartered in Yokneam, Israel, InMode Ltd. plays a key role in advancing radiofrequency-based solutions for aesthetic and wellness procedures worldwide.